Research Article: The Effect of Platelet Activity, ABCB Genetic Polymorphism, and Renal Function on the Development of Ticagrelor-Related Dyspnea in Patients with Acute Coronary Syndrome
Introduction:
Ticagrelor in combination with aspirin is a first-line therapy in patients with acute coronary syndrome (ACS) who underwent percutaneous transluminal coronary angioplasty (PTCA) with stent implantation. – The most recent guidelines by the European Society of Cardiology (ESC) and the American Heart Association (AHA) recommend this dual antiplatelet therapy as a first-line therapy for patients with ACS irrespective of initial treatment strategy. , , New data suggest that Ticagrelor in combination with aspirin…
Read more